Patients with muscle-invasive bladder cancer who underwent whole pelvis radiation showed improved cancer-specific survival and overall survival.
Standard treatment for muscle-invasive bladder cancer is neoadjuvant chemotherapy followed by radical cystectomy, but more than half of all patients relapse within 3 years. Previous trials of ...
AstraZeneca has revealed the data for Imfinzi in muscle-invasive bladder cancer (MIBC) that it hopes will be enough to secure FDA approval – although the jury is out on that. The clinical ...
A recent study reveals that extended lymphadenectomy offers no survival advantage over standard lymphadenectomy for patients ...
In a phase 1 trial in patients with non-muscle invasive bladder cancer, Aura’s viruslike drug conjugate (VDC) bel-sar—along with infrared light activation—completely eradicated the tumors of ...
A bladder ultrasound gives providers clues about how the bladder expands and holds urine. This article lists conditions ...
This study included a review of consecutive patients diagnosed with NMIBC between January 2005 and May 2023 to identify ...
data for the first time and an exploratory analysis among patients with bladder primary tumors (muscle-invasive bladder cancer [MIBC]). Consistent DFS benefit with nivolumab versus placebo was ...
Patients with advanced bladder cancer that had spread to other parts of the body (metastasized) have responded well in a phase I clinical trial of an investigational drug, TYRA-300.
Liver fibrosis is a progressive and potentially reversible condition that results from chronic liver damage, which can be ...
PPF is identified by decline in lung function, worsening symptoms, and increased fibrosis on imaging ... Naccache JM, Gibiot Q, Monnet I, et al. Lung cancer and interstitial lung disease: a ...